Critsal B RotaCaps is a combination therapy designed to manage asthma and chronic obstructive pulmonary disease (COPD). It contains Levosalbutamol (100 mcg), a fast-acting bronchodilator that relaxes airway muscles for easier breathing, and Beclomethasone Dipropionate (100 mcg), a corticosteroid that reduces inflammation and prevents airway narrowing. Together, these components help improve airflow, control asthma symptoms, and prevent respiratory complications.
The medication works by relaxing the smooth muscles of the airways while reducing swelling and mucus production. This dual action provides both immediate relief from bronchospasms and long-term protection against respiratory inflammation. Critsal B RotaCaps is beneficial for individuals suffering from persistent asthma or COPD, helping to reduce symptoms such as breathlessness, wheezing, and chest tightness. It is particularly useful for people who require regular maintenance therapy to keep their condition under control.
This medication is designed for inhalation using a Rotahaler device, ensuring that the active ingredients reach deep into the lungs for maximum effectiveness. It should be used exactly as prescribed by a healthcare professional to achieve the best results. Patients are advised to rinse their mouths after each use to prevent oral infections, a common side effect of inhaled corticosteroids.
While generally well tolerated, Critsal B RotaCaps may cause mild side effects, including dry mouth, sore throat, cough, dizziness, or tremors. These effects are usually temporary, but if any severe reactions occur, medical attention should be sought immediately.